Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition

Figure 3 Effects of chemokine ligand 20 on expression of epithelial-mesenchymal transition-related proteins. A: Representative Western blots for epithelial marker E-cadherin, mesenchymal marker vimentin, total and phosphorylated AKT (t-AKT and p-AKT), and β-catenin in Hep3B and Huh7 cells after treatment with chemokine ligand 20 (CCL20) for 48 h. B: Quantification of Western blotting by gray value analysis; ^aP < 0.05 vs Control.